Probity Advisors’s Medtronic MDT Stock Holding History

Probity Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$940K	Sell	12,015 -1,237	-9%	-$99.8K	0.13%	110
2026 Q1	$1.15M	Sell	13,252 -163	-1%	-$15.6K	0.18%	91
2025 Q4	$1.29M	Sell	13,415 -762	-5%	-$74K	0.21%	82
2025 Q3	$1.35M	Buy	14,177 +373	+3%	+$34.3K	0.22%	78
2025 Q2	$1.2M	Buy	13,804 +4,179	+43%	+$354K	0.21%	82
2025 Q1	$865K	Buy	9,625 +910	+10%	+$81.4K	0.17%	102
2024 Q4	$696K	Buy	8,715 +804	+10%	+$69.6K	0.13%	114
2024 Q3	$712K	Buy	7,911 +718	+10%	+$60.4K	0.14%	118
2024 Q2	$566K	Buy	7,193 +2,544	+55%	+$209K	0.12%	133
2024 Q1	$405K	Buy	4,649 +125	+3%	+$10.7K	0.08%	161
2023 Q4	$373K	Buy	+4,524	New	+$345K	0.08%	161
2023 Q3	–	Sell	-2,383	Closed	-$210K	–	186
2023 Q2	$210K	Buy	+2,383	New	+$205K	0.05%	184

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Probity Advisors's MDT Position: Q2 2026 in Review

Probity Advisors reduced its Medtronic (MDT) stake by 9.3% in Q2 2026, selling an estimated $99.8K and leaving 12,015 shares worth $940K. The position accounts for 0.13% of the portfolio, ranked #110.

Probity Advisors first reported a position in MDT in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.35M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Probity Advisors held 12,015 shares of Medtronic worth $940K as of Q2 2026.
Probity Advisors sold 1,237 Medtronic shares in Q2 2026, an estimated $99.8K.
Medtronic made up 0.13% of Probity Advisors's portfolio in Q2 2026, its #110 holding.
Probity Advisors first reported a position in Medtronic in Q2 2023 and has held it in 12 quarters since.
Probity Advisors's Medtronic position peaked at $1.35M in Q3 2025.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Probity Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.